BUZZ-Cassava Sciences rises after US DOJ closes probe into company

Reuters

Feb 19

** Shares of drug developer Cassava Sciences SAVA.O rise 2.82% to $2.19 premarket

** Co says the U.S. Department of Justice has ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer's drug simufilam

** Co says probe ended four months after the Justice Department dismissed a criminal indictment accusing former adviser Hoau-Yan Wang, who allegedly submitted false data regarding the drug

** SAVA shares fell 16.1% in 2025

(Reporting by Gnaneshwar Rajan in Bengaluru)

((Gnaneshwar.Rajan@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2612138288"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612138288\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612138288?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-19 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612138288","market":"us","top_or_hot":-1,"title":"BUZZ-Cassava Sciences rises after US DOJ closes probe into company","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Cassava Sciences rises after US DOJ closes probe into company</title></head><body><p>** Shares of drug developer Cassava Sciences <span>SAVA.O</span> rise 2.82% to $2.19 premarket</p><p>** Co <span>says</span> the U.S. Department of Justice has ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer's drug simufilam</p><p>** Co says probe ended four months after the Justice Department dismissed a criminal indictment accusing former adviser Hoau-Yan Wang, who allegedly submitted false data regarding the drug</p><p>** SAVA shares fell 16.1% in 2025 </p><p> (Reporting by Gnaneshwar Rajan in Bengaluru)</p><p> ((Gnaneshwar.Rajan@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Cassava Sciences rises after US DOJ closes probe into company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Cassava Sciences rises after US DOJ closes probe into company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-19 21:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Cassava Sciences rises after US DOJ closes probe into company</title></head><body><p>** Shares of drug developer Cassava Sciences <span>SAVA.O</span> rise 2.82% to $2.19 premarket</p><p>** Co <span>says</span> the U.S. Department of Justice has ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer's drug simufilam</p><p>** Co says probe ended four months after the Justice Department dismissed a criminal indictment accusing former adviser Hoau-Yan Wang, who allegedly submitted false data regarding the drug</p><p>** SAVA shares fell 16.1% in 2025 </p><p> (Reporting by Gnaneshwar Rajan in Bengaluru)</p><p> ((Gnaneshwar.Rajan@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL4N3ZF129:1","article_id":"2612138288","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612138288","pubTimestamp":1771509267,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Cassava Sciences rises after US DOJ closes probe into company** Shares of drug developer Cassava Sciences SAVA.O rise 2.82% to $2.19 premarket** Co says the U.S. Department of Justice has ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer's drug simufilam** Co says probe ended four months after the Justice Department dismissed a criminal indictment accusing former adviser Hoau-Yan Wang, who allegedly submitted false data regarding the drug** SAVA shares fell 16.1% in 2025   ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4547":"WSB热门概念","BK4585":"ETF&股票定投概念","BK4007":"制药","SAVA":"Cassava Sciences Inc"},"translate_title":"美国司法部结束对木薯科学公司的调查后，BUZZ股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SAVA":0.9},"content_text":"BUZZ-Cassava Sciences rises after US DOJ closes probe into company** Shares of drug developer Cassava Sciences SAVA.O rise 2.82% to $2.19 premarket** Co says the U.S. Department of Justice has ended its probe into the company regarding allegations of research misconduct for its experimental Alzheimer's drug simufilam** Co says probe ended four months after the Justice Department dismissed a criminal indictment accusing former adviser Hoau-Yan Wang, who allegedly submitted false data regarding the drug** SAVA shares fell 16.1% in 2025  (Reporting by Gnaneshwar Rajan in Bengaluru) ((Gnaneshwar.Rajan@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}